ClarIDHy: A Global, Phase 3, Randomized, Double-Blind Study of Ivosidenib (IVO) vs. Placebo in Patients with Advanced Cholangiocarcinoma (CC) with a … | OncologyPRO
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.